Details for New Drug Application (NDA): 013334
✉ Email this page to a colleague
NDA 013334 describes DECADRON W/ XYLOCAINE, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the DECADRON W/ XYLOCAINE profile page.
The generic ingredient in DECADRON W/ XYLOCAINE is dexamethasone sodium phosphate; lidocaine hydrochloride. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone sodium phosphate; lidocaine hydrochloride profile page.
The generic ingredient in DECADRON W/ XYLOCAINE is dexamethasone sodium phosphate; lidocaine hydrochloride. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone sodium phosphate; lidocaine hydrochloride profile page.
Summary for 013334
| Tradename: | DECADRON W/ XYLOCAINE |
| Applicant: | Merck |
| Ingredient: | dexamethasone sodium phosphate; lidocaine hydrochloride |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4MG PHOSPHATE/ML;10MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
